FFR, IVUS and OCT in Chronic Coronary Syndromes

Lecture given by Dr. Mario Araya (Chile) on FFR, IVUS and CTO in acute coronary syndromes at SOLACI-SBHCI’16, Rio de Janeiro, Brazil.

Recorded by TV Med – June 8, 2016.

More articles by this author

Use of IFR and Bioresorbable Stent in Complex Multivessel Disease

Location: Hospital dos Servidores do Estado (HSE). Operators: Valério Fuks, Marcus Lacativa, André Duque Estrada, Maria Cristina Ferreira. Chairpersons: Marcelo Antônio Cartaxo Queiroga Lopes, Constantino Gonzalez...

Complex coronary angioplasty in octogenarian

Location: Instituto Nacional de Cardiologia Laranjeiras. Operators: Sérgio Leandro, Luiz Kohn. Chairpersons:  Maria de Lourdes Montedonio Santos, Breno Oliveira Almeida. Panelists: Sérgio Martins Leandro, Rodrigo de Franco...

TAVR in Aortic Valve Stenosis with LOTUS

Operators: Alexandre Abizaid, Dimytri Siqueira, David Lebihan. Chairpersons: Martin Leon, José Eduardo Morais Rego Sousa. Panelists: José Armando Mangione, Josep Rodés Cabau, Fabio Sândoli de Brito...

Implant of the Melody Valve in Bioprosthesis

Operators: Carlos Pedra, Rodrigo Costa. Chairpersons:  Alejandro Peirone, Luiz Alberto Christiani . Debaters:  Luiz Carlos Giuliano, Celia Maria Camelo Silva, Fábio Bergman, Jean Marcelo Ferreira da...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...